Lantheus Holdings, Inc. ("Lantheus") (NASDAQ:LNTH), a company committed to improving patient outcomes through diagnostics, radiotherapeutics and artificial intelligence solutions that enable clinicians to Find,
JMP Securities analyst David Turkaly initiates coverage on Lantheus Holdings (NASDAQ:LNTH) with a Market Outperform rating and announces Price Target of $120.
U.S. stocks traded slightly lower, with the Dow Jones dropping around 30 points on Thursday. Here are some big stocks recording gains in today’s session.